Menu
GeneBe

14-65561728-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001371533.1(FUT8):c.165A>G(p.Gln55=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.695 in 1,612,804 control chromosomes in the GnomAD database, including 391,057 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37609 hom., cov: 33)
Exomes 𝑓: 0.69 ( 353448 hom. )

Consequence

FUT8
NM_001371533.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.803
Variant links:
Genes affected
FUT8 (HGNC:4019): (fucosyltransferase 8) This gene encodes an enzyme belonging to the family of fucosyltransferases. The product of this gene catalyzes the transfer of fucose from GDP-fucose to N-linked type complex glycopeptides. This enzyme is distinct from other fucosyltransferases which catalyze alpha1-2, alpha1-3, and alpha1-4 fucose addition. The expression of this gene may contribute to the malignancy of cancer cells and to their invasive and metastatic capabilities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 14-65561728-A-G is Benign according to our data. Variant chr14-65561728-A-G is described in ClinVar as [Benign]. Clinvar id is 402887.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.803 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.878 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FUT8NM_001371533.1 linkuse as main transcriptc.165A>G p.Gln55= synonymous_variant 3/11 ENST00000673929.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FUT8ENST00000673929.1 linkuse as main transcriptc.165A>G p.Gln55= synonymous_variant 3/11 NM_001371533.1 P1Q9BYC5-1

Frequencies

GnomAD3 genomes
AF:
0.701
AC:
106415
AN:
151896
Hom.:
37565
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.731
Gnomad AMI
AF:
0.726
Gnomad AMR
AF:
0.701
Gnomad ASJ
AF:
0.692
Gnomad EAS
AF:
0.900
Gnomad SAS
AF:
0.775
Gnomad FIN
AF:
0.608
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.677
Gnomad OTH
AF:
0.672
GnomAD3 exomes
AF:
0.705
AC:
176424
AN:
250400
Hom.:
62843
AF XY:
0.704
AC XY:
95205
AN XY:
135298
show subpopulations
Gnomad AFR exome
AF:
0.734
Gnomad AMR exome
AF:
0.704
Gnomad ASJ exome
AF:
0.691
Gnomad EAS exome
AF:
0.902
Gnomad SAS exome
AF:
0.769
Gnomad FIN exome
AF:
0.618
Gnomad NFE exome
AF:
0.670
Gnomad OTH exome
AF:
0.677
GnomAD4 exome
AF:
0.694
AC:
1013653
AN:
1460790
Hom.:
353448
Cov.:
48
AF XY:
0.695
AC XY:
505249
AN XY:
726710
show subpopulations
Gnomad4 AFR exome
AF:
0.726
Gnomad4 AMR exome
AF:
0.706
Gnomad4 ASJ exome
AF:
0.687
Gnomad4 EAS exome
AF:
0.902
Gnomad4 SAS exome
AF:
0.771
Gnomad4 FIN exome
AF:
0.620
Gnomad4 NFE exome
AF:
0.682
Gnomad4 OTH exome
AF:
0.705
GnomAD4 genome
AF:
0.701
AC:
106516
AN:
152014
Hom.:
37609
Cov.:
33
AF XY:
0.702
AC XY:
52161
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.731
Gnomad4 AMR
AF:
0.701
Gnomad4 ASJ
AF:
0.692
Gnomad4 EAS
AF:
0.900
Gnomad4 SAS
AF:
0.774
Gnomad4 FIN
AF:
0.608
Gnomad4 NFE
AF:
0.677
Gnomad4 OTH
AF:
0.675
Alfa
AF:
0.680
Hom.:
39677
Bravo
AF:
0.707
Asia WGS
AF:
0.847
AC:
2943
AN:
3476
EpiCase
AF:
0.668
EpiControl
AF:
0.663

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJun 14, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Congenital disorder of glycosylation with defective fucosylation 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
FUT8-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMay 22, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
Cadd
Benign
7.5
Dann
Benign
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2229677; hg19: chr14-66028446; API